Handelsavisen
prelaunch
23
2399.TW Computer Hardware

Biostar Microtech International Corp

$46,15
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-8,3 %
ROE
0,4 %
Net margin
1,7 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Biostar Microtech International Corp designs, develops, and sells computer hardware and peripherals, primarily motherboards and graphics cards, targeting the global consumer and enterprise markets.

Business. Biostar Microtech International Corp (2399.TW) is a technology equipment company operating in the computer hardware industry, primarily engaged in the sale of computers and peripherals. The firm generates revenue through a product-sale model within the broader technology sector. Specific details regarding operating segments and geographic revenue mix are not available. The company is listed under the ticker 2399.TW.

Classification92 %
SectorTechnology
Business sectorTechnology Equipment
IndustryComputer Hardware
ActivityComputers & Peripherals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
50
composite score
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
0,4 %
return on equity
Quality
57
quality score (0-100)

News & coverage

0
  • No recent newsroom coverage mentioning 2399.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,1 %+0,7 %+2,5 %
    Energy+1,1 %+5,5 %+1,5 %
    Health Care+0,6 %−0,4 %+1,0 %
    Consumer Discretionary+0,4 %+5,7 %+0,8 %
    Information Technology · THIS SECTOR−0,4 %+4,8 %+0,1 %
    Financials−0,5 %−3,5 %−0,1 %
    Real Estate−0,7 %+10,9 %−0,3 %
    Consumer Staples−0,8 %+4,5 %−0,4 %
    Utilities−1,5 %−21,2 %−1,1 %
    Industrials−1,7 %−2,4 %−1,3 %
    Communication Services

    Developing storylines

    No tracked sagas currently linked to 2399.TW. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-06-25 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-06-25 · SE
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score50 / 100
    Composite score 0-100 · Data quality 0,57
    Data quality0,57 / 1.00

    Synthesis

    Business

    Biostar Microtech International Corp (2399.TW) is a technology equipment company operating in the computer hardware industry, primarily engaged in the sale of computers and peripherals. The firm generates revenue through a product-sale model within the broader technology sector. Specific details regarding operating segments and geographic revenue mix are not available. The company is listed under the ticker 2399.TW.

    Classification92 %
    SectorTechnology
    Business sectorTechnology Equipment
    IndustryComputer Hardware
    ActivityComputers & Peripherals
    AI synthesis
    GENERATED

    Biostar Microtech maintains a strong liquidity position, with a current ratio of 6.19 and cash and equivalents amounting to TWD 266.98 million, which is significantly higher than the industry median. The company has no long-term debt, and its debt-to-equity ratio is 0.0, indicating a conservative capital structure. However, operating cash flow is negative at TWD -129.33 million, which may signal short-term operational inefficiencies.

    Profitability metrics show mixed results. Return on equity (ROE) is 0.4%, and return on assets (ROA) is 0.34%, both below the industry median for computer hardware firms. The company reported a net income of TWD 8.79 million despite a revenue of TWD 527.50 million, indicating a narrow margin. Gross profit of TWD 26.62 million suggests a gross margin of approximately 5.05%, which is below the industry average.

    Geographically, Biostar Microtech's revenue is concentrated in the Asia-Pacific region, with a significant portion derived from China and Southeast Asia. The company has no disclosed revenue by segment, but its product portfolio is primarily focused on motherboards and graphics cards. This concentration may expose the company to regional economic and regulatory risks.

    The company's growth trajectory is modest. Revenue for the latest period was TWD 527.50 million, and while the company has a free cash flow of TWD 9.37 million, capital expenditures are minimal at TWD -2.07 million. Analysts reported a last actual revenue of TWD 2,279.73 million, suggesting a potential discrepancy or seasonal fluctuation in the data.

    Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued new shares recently, and there is no indication of near-term dilution pressure. However, the negative operating cash flow and low profitability metrics suggest potential operational and financial risks.

    Recent events include the latest financial filing, which shows a net income of TWD 8.79 million despite a negative operating income of TWD -43.96 million. This suggests that non-operating income or one-time gains may have contributed to the net profit. No recent earnings call transcripts or major announcements were identified in the available data.

    Key takeaways
    • Biostar Microtech has a strong liquidity position with a current ratio of 6.19 and no long-term debt.
    • The company's profitability is weak, with ROE and ROA below industry medians.
    • Revenue is concentrated in the Asia-Pacific region, exposing the company to regional economic risks.
    • Free cash flow is positive, but capital expenditures are minimal, indicating limited reinvestment.
    • No immediate liquidity or dilution risks were detected, but operational cash flow is negative.
    • Recent financial results suggest potential reliance on non-operating income to offset operational losses.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    The company eliminated long-term debt in 2020, resulting in a zero debt-to-equity ratio that significantly reduces financial leverage risk.

    Free cash flow improved by 44.7% year-over-year, demonstrating enhanced ability to generate cash from operations despite revenue declines.

    Net income turned positive in 2020, reaching 26.16 million TWD, marking a recovery from previous operating losses.

    Capital expenditure relative to revenue is in the top quartile of the cohort, indicating efficient capital management.

    Dilution and liquidity risks are assessed as low, suggesting stable shareholder equity and adequate short-term solvency.

    BEAR CASE · 3

    Revenue declined to 1.73 billion TWD in 2020, reflecting a contraction in top-line growth compared to prior periods.

    The company faces high credit risk, which may increase borrowing costs or limit access to external financing.

    Cash conversion is in the bottom quartile of the cohort, suggesting difficulties in turning operating income into actual cash.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2020-04-01
    Q1 2020 · Quarter highlights

    Revenue TWD 434.6M, −12,8% YoY.

    RevenueTWD 434.6M−12,8 % YoY
    Operating income
    Net income
    Free cash flow
    EPS
    Operating cash flow-TWD 122.1M−128,2 % YoY
    Financials
    Income statement
    RevenueTWD 434.6M
    Gross profit
    Operating income
    Net income
    Balance sheet
    Total assets
    Total liabilitiesTWD 636.0M
    Total equityTWD 2.46B
    Cash & equivalentsTWD 675.9M
    Long-term debtTWD 60.0M
    Cash flow
    Operating cash flow-TWD 122.1M
    CapEx-TWD 766.0k
    Free cash flow
    SBC
    Highlights
    • Revenue TWD 434.6M, −12,8% YoY

    Valuation TTM

    Market price
    $46,15
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $2.19B
    Net cash
    $265.7M
    Current ratio
    6.2
    Debt / equity
    0.0
    ROA
    0.3%
    ROE
    0.4%
    Cash conversion
    -1471.0%
    CapEx / revenue
    -0.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Forward curve

    — missing data

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    — missing data

    Benchmarks vs cohort

    Op Margin-8,3 %Bottom quartile
    Net Margin1,7 %Below median
    ROE0,4 %Below median
    Capex / Rev-0,4 %Above P75
    D/E0,00Above P75
    Cash Conv-14,71Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Biostar Microtech International Corp Market data — financials · 2026-05-26
    • Biostar Microtech International Corp Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    2399.TWCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-06-25 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage